All In Biotech

Drug Trial Radar · NCT02848326

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Dosing Regimens Of Oral AGN-241689 In Episodic Migraine Prevention

Last checked: Nov 20, 2026Latest source record: Dec 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 834 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

834

Actual

Start

Sep 6, 2016

Primary completion

Apr 2, 2018

Study completion Apr 23, 2018

Sponsor

Lead sponsor
AllerganAbbVie (ABBV)
Sponsor type
Industry
First posted
Jul 28, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and tolerability of the following doses of atogepant (AGN-241689): 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60 mg BID for the prevention of episodic migraine and will characterize the dose/response relationship.

Conditions

  • Migraine, With or Without Aura

Interventions

  • AtogepantDrug

    Atogepant capsule.

  • Placebo-matching AtogepantDrug

    Placebo-matching atogepant capsule.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Mean Monthly Migraine Days (Migraine/Probable Migraine Headache Days) Across the 12-Week Treatment PeriodTime frame: Baseline (First 28 Days of Screening/Baseline Period) to Week 12

Locations

75 sites in 1 country. Site status is shown where the registry gives one.

  • Achieve Clinical Research

    Birmingham, Alabama

  • Radiant Research, Inc.

    Chandler, Arizona

  • The Research Center of Southern California, LLC

    Carlsbad, California

  • Neuro-Pain Medical Center, Inc

    Fresno, California

  • Irvine Center for Clinical Research

    Irvine, California

  • Downtown LA Research Center, Inc.

    Los Angeles, California

  • Excell Research

    Oceanside, California

  • Artemis Institute for Clinical Research

    San Marcos, California

  • Diablo Clinical Research Inc

    Walnut Creek, California

  • Advanced Neurosciences Research

    Fort Collins, Colorado

  • Hartford Headache Center

    East Hartford, Connecticut

  • Associated Neurologists of Southern Connecticut, P. C.

    Fairfield, Connecticut

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • The George Washington University

    Washington D.C., District of Columbia

  • Clinical Research South Florida

    Coral Gables, Florida

  • Infinity Clinical Research

    Hollywood, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Clinical Neuroscience Solutions Inc

    Jacksonville, Florida

  • Meridien Research

    Maitland, Florida

  • Suncoast Research

    Miami, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Clinical Neuroscience Solutions

    Orlando, Florida

  • Palm Beach Neurological Center / Advanced Research Consultants, Inc.

    Palm Beach Gardens, Florida

  • Suncoast Neuroscience Associates, Inc.

    St. Petersburg, Florida

  • Infinity Clinical Research LLC

    Sunrise, Florida

  • Meridien Research

    Tampa, Florida

  • Neurology Research Institute Palm Beach

    West Palm Beach, Florida

  • Institute for Advanced Medical Research

    Alpharetta, Georgia

  • Radiant Research

    Atlanta, Georgia

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • iResearch Atlanta, LLC

    Decatur, Georgia

  • Pediatric and Adolescent NeuroDevelopmental Associates (PANDA) Neurology

    Sandy Springs, Georgia

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Northwest Clinical Trials, Inc.

    Boise, Idaho

  • Healthcare Research Network II, LLC

    Blue Island, Illinois

  • Rowe Neurology Institute

    Lenexa, Kansas

  • Boston Clinical Trials Inc

    Boston, Massachusetts

  • Northeast Medical Research Associates, Inc.

    North Dartmouth, Massachusetts

  • Medvadis Research Corporation

    Watertown, Massachusetts

  • New England Regional Headache Center

    Worcester, Massachusetts

Showing 40 of 75 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.